Diabetes treatment is constantly progressing, with new therapeutic options emerging to improve patient outcomes. Recent studies have focused on GLP-1 and GIP receptor agonists, a category of drugs that mimic the https://safapnop067505.madmouseblog.com/19713329/emerging-glp-1-and-gip-receptor-agonists-a-new-era-in-diabetes-treatment